(Q68433476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

M J Barros

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

P J Rees

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 September 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

371-375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

Influence of age on response to ipratropium and salbutamol in asthma

24 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Role of the parasympathetic system in airway obstruction due to emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Maximum achievable bronchodilatation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Average Normal Values for the Forced Expiratory Volume in White Caucasian Males

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Bronchodilatation and the site of airway resistance in severe chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Reduced β-adrenoceptor sensitivity in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Reversible Airflow Obstruction: Clinical Spectrum and Responsiveness to Anticholinergic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Asthma vs. Non-Specific Reversible Airflow Obstruction: Clinical Features and Responsiveness to Anticholinergic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

A comparison of the bronchodilator activity of Sch 1000 and salbutamol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Prognosis in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Dose response of ipratropium assessed by two methods

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Determination of bronchodilation in the clinical pulmonary function laboratory. Role of changes in static lung volumes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Should the FVC be considered in evaluating response to bronchodilator?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

A Comparative Study of Various Combinations of Ipratropium Bromide and Metaproterenol in Allergic Asthmatic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Bronchodilator Action of the Anticholinergic Drug, Ipratropium Bromide (Sch 1000), as an Aerosol in Chronic Bronchitis and Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

The effect of atropine inhalation in "irreversible" chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2808%2980071-6

7 January 2021

10.1016/S0954-6111(08)80071-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147295%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference